Argonaut
Executive Summary
The chemical synthesis of small molecules through traditional medicinal chemistry techniques is a manual, repetitive and time-consuming process that slows down pharmaceutical development. Argonaut Technologies was founded to address this bottleneck through the development of novel instruments and reagents that apply solid-phase synthesis techniques to the production of small molecules.
You may also be interested in...
Coronavirus Update: US Public Confidence In COVID-19 Vaccines Declines
Confidence in the vaccine has slipped in the US, regardless of political affiliation.
Janssen’s Amivantamab Combo Shows Promise In First-Line NSCLC
Janssen presents highly encouraging interim results at ESMO from the CHRYSALIS study with a combination of amivantamab and lazertinib. Based on the data, the global Phase III MARIPOSA study, which will assess the combo versus blockbuster Tagrisso, will begin next month including in South Korea, home to lazertinib's originator.
China Detains Legend Biotech CEO, Exposes Genetic Material Minefield
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.
Need a specific report? 1000+ reports available
Buy Reports